Deardorf Caren (CIK 1871152) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Sell CRNX (16,300 shares), Sell CRNX (5,925 shares), Buy CRNX (5,925 shares), Buy CRNX (6,900 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Sell | 16,300 | $1.4M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Sell | 5,925 | $503,625 |
| 2026-06-22 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Buy | 5,925 | $0 |
| 2025-06-13 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Buy | 6,900 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01